UnknownN/Aketamine

Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval

NCT ID

NCT03458143

Target Enrollment

20 participants

Start Date

2018-02-12

Est. Completion

2018-03-31

About This Study

This study evaluates the effect of the addition of ketamine to a conscious sedation protocol including remifentanil during oocyte retrieval. The investigators will have 2 groups with different target effect site concentrations, namely 150 ng/ml and 200 ng/ml.

Conditions Studied

Oocyte RetrievalSedation, ConsciousVentilatory Depression

Interventions

•Ketamine 150 ng/ml
•Remifentanil
•Oocyte retrieval
•Ketamine 200 ng/ml

Eligibility

Sex:FEMALE

Age:18 Years - N/A

Healthy Volunteers:Yes

View full eligibility criteria

Inclusion Criteria:

* patients having an oocyte retrieval

Exclusion Criteria:

* BMI \> 30
* endometriosis
* contraindications to ketamine

Study Locations (1)

Erasme University Hospital

Brussels, Belgium